drugset / Trial / NCT07313670
Outcome of Using Hydrocortisone in Early Treatment of Pediatric Septic Shock
RandomizedParallel-groupOpen-labelTreatment
Summary
Although, hydrocortisone has shown promise in managing refractory shock, its role in early septic shock management remains unclear. This study aims to provide robust evidence on the clinical and hemodynamic outcomes of early hydrocortisone use in pediatric septic shock, contributing to standardized treatment protocols and improved survival rates.
Timeline
- Start
- 2025-07-01
- Primary completion
- 2025-12-30
- Completion
- 2025-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Hydrocortisone | Other / unclassified | 2 mg/kg | Intravenous |